Translational Science and Therapeutics News

Taking a frothy risk to advance gene therapy

Taking a frothy risk to advance gene therapy

Fred Hutch scientists hope foam could be a cost-reducing, access-enhancing vehicle for delivering future gene therapies
Hutch NewsJune 03, 2024
Could a medicated foam make gene therapies more accessible?

Could a medicated foam make gene therapies more accessible?

In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies.
News ReleasesMay 29, 2024
500 replication origins in the yeast genome? Try 5000!

500 replication origins in the yeast genome? Try 5000!

From the Bedalov Lab, Translational Science and Therapeutics and Human Biology Divisions
Science SpotlightMarch 20, 2024